期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

三阴性乳腺癌临床病理特征及预后回顾性分析 被引量：4

Triple Negative Breast Cancer Clinical and Pathological Features and Prognosis Retrospective Analysis
下载PDF
导出
摘要 回顾三阴性乳腺癌(TNBC)病例,进行临床病理特征对比及预后分析。收集2005年1月至2006年12月在我院经手术治疗,经病理组织学确诊,并可随访到的348例乳腺癌病例资料,研究其临床病理特征,分析预后。结果 TNBC多见于50岁以前未绝经女性,肿块>2cm(72.2%)比例高于非三阴性乳腺癌(non-TNBC)51.4%(P<0.05),复发转移率显著高于non-TNBC(P<0.05)。5年无病生存率(DFS),TNBC 62.8%低于non-TNBC 79.6%(P<0.05)。5年总生存率(OS),TNBC 73.6%低于non-TNBC 89.8%(P<0.05)。三阴性乳腺癌恶性程度高,转移复发率高,预后差,生存率低,其有效治疗方案需进一步研究。 Review the data of triple negative breast cancer （TNBC） cases, and compared clinical and pathological teatures and prognosis. The clinical and pathological data of 348 cases of breast cancer patients treated by surgery from January 2005 to December 2006 in the First Affiliated Hospital of Liaoning Medical College, with histopathology confirmed, and can follow--up to study the clinical disease characteristics, analysis of prognosis. Compared with other breast cancer, tri- ple-negative breast cancer correlated with younger （〈50y） and tumor more than 2cm （72.2%） higher than non-triple negative breast cancer （non-TNBC） 51.4% （P〈0.05）. The recurrence rate was significantly higher than non-TNBC （P〈0.05）. The TNBC 5-year disease--free survival （DFS） 62.8% lower than the non- TNBC 5-year disease-free survival （DFS） 79.6% （P〈0.05）. The TNBC 5-year overall survival （OS）, 73.6% lower than non-TNBC 5-year o- verall survival （OS） was 89.8 % （P〈0.05）. Triple negative breast cancer, malignant high degree of metastasis and recur- rence rates compared with other types of breast cancer, poor prognosis, survival rate, effective treatment options require further study.
作者 赵夷 胡婷嫣 李锦成 张韶光 李雅勋
机构地区 辽宁医学院附属第一医院乳腺外科
出处 《医学与哲学（B）》 2013年第5期37-39,共3页 Medicine & Philosophy(B)
关键词 三阴性乳腺癌 临床病理特征 预后 triple-- negative breast cancer, clinicopathological characteristics, prognosis
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Carey L A, Perou C M, Livasy C A ,et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study[J]. Jour- nal of the American Medical Association, 2006,295 (5:1) : 2492 - 2502.
  • 2Amos K D,Adamo B,Anders C K, et al. Triple-Negative Breast Cancer: An Up- date on Neoadjuvant Clinical Trials[J] Interna- tional Journal of Breast Cancer,2012,2012:385978.
  • 3张超杰.乳腺癌诊治过程中的多学科协作[J].医学与哲学（B）,2009,30(8):4-5. 被引量：10
  • 4Bauer K,Brown M, Cress R, et al. Descriptive analysis of estrogen receptor (ER) - negative, progesterone receptor (PR) - negative, and HER-2-negative invasive breast cancer,the so-called triple -negative phenotype: A population-based study from the Call fornia cancer registry[J]. Cancer, 2007,109 (9) : 1721 - 1728.
  • 5Morris G, Naidu S, Topham A, et al. Differences in breast carcinoma characteristics in newly diagnosed African American and Caucasian patients: A single-institution compilation compared with the Na- tional Cancer Institute's Surveillance, Epidemiology, and End Re- sults data base[J]. Cancer,2007,110(4) :876- 884.
  • 6Dent R, Trudeau M, Pritchard K I, et al. Triple negative breast cancer clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007,13, 4429 4434.
  • 7Bauer K R, Brown M ,Cress R D, et al. Descriptive analysis of es trogen receptor (ER) negative progesterone receptor (PR) negative and HER-2 negative invasive breast cancer, the so called triple negative phenotype a population based study from the California cancer registry[J]. Cancer, 2007,109(9) : 1721 - 1728.
  • 8Dent R, Trudeau M, Pritchard K I, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [J]. Clinical Cancer Research,2007,13(15 Pt 1):4429-4434.
  • 9Gucalp A, Traina T A. Triple- Negative Breast Cancer: Adjuvant The rapeutic Options[J]. Chemotherapy Research and Practice, 2011,2011:696208.
  • 10Lin N U, Vanderplas A, Hughesetal M E. Clinicopathological fea- tures and sites of recurrence according to breast cancer subtype in the National Comprehensive Cancer Network (NCCN)IDa. ASCO Meeting Abstracts, 2009,27 : abstract 543.

二级参考文献13

共引文献17

同被引文献46

  • 1Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior breast cancersubtypes[J].JClinOncol,2010,28(20):3271- 3277.
  • 2Amos K D.Adamo Bv Anders C Kv et a1. Triple-negative breast cancer: an update on neoadjuvant clinical trials[J]. Int J Breast Cancer, 2012. 2012: 385978.
  • 3Tischkowitz M.Brunet J Sv Begin L R.et a1. Use of immunohistochemical markers can refine prognosis in triple negative breast caneere]]. BMC Cancer,2007. 7: 134.
  • 4Rastogi P. Anderson S J. Bear H D. et a!. Preoperative chemotherap updates of national surgical adjuvant breast and bowel projeprotocols B-18 and B-27[J]. J Clin Onco1.2008.26(S) :778-785.
  • 5Berry D A, Cirrineione C, Henderson I C. et a1. Estrogen-receptor status and outcomes of modem chemotherapy for patients with node-positive breast cancer[J]. AMA.2007 .29S(20) :1658-1667.
  • 6Byrski T. Gronwald J. Huzarski T. et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy [J]. J Clin Onco1.2010.28(3) :375-379.
  • 7Sliver D P. Richardson A L, Eklund A C. et al. Efficacy of neodjuvant Cisplatin in triple-negtive breast cancer[J]. J Clin Oncol , 2010. 28(7): 1145-11S3.
  • 8Cortazar P.Zhang L. Untch M,?: a!. Meta-analysis results from the collaborative trials in neoadjuvant breast cancer (CTNeoBC) [J]. Cancer Res, 2012. 72( 24 Suppl) : Abstract Sl - S11.
  • 9Dent R, Trudeau M, Pritchard K I, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J]. Clin Cancer Res, 2007,13 (15Pt 1) :4429-4434.
  • 10Rakha E A,EI-Sayed M E,Green A R,et al. Prognosticmarkers in triple-negative breast cancer[J]. Cancer, 2007,109 (1) : 25 - 32.

引证文献4

二级引证文献26

医学与哲学（B）
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部